Prostate Cancer Clinical Trials

Showing 1021-1040 of 1,222 trials

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel

NCT01795703

The purpose of this study is to investigate the safety and efficacy of abiraterone in participants with metastatic castration-resistant prostate cancer (mCRPC) who have received docetaxel-based chemotherapy (treatment of disease, usually cancer, by chemical agents).

Prostate Cancer

Janssen Research & Development, LLC47 participantsStarted Jun 2012

Asahi, Japan • Fukuoka, Japan • Kanazawa, Japan +15 more locations

COMPLETEDPHASE2

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

NCT01541007

Cabazitaxel has shown significant efficacy as second line chemotherapy after Docetaxel in men with metastatic castration resistant prostate cancer. This was demonstrated in the Tropic Study where Cabazitaxel showed survival superiority compared to mitoxantrone. Almost one in 4 patients treated with Cabazitaxel in this study required dose reductions or dose delays or stopped treatment due to toxicity. ConCab examines another scheduling for cabazitaxel to see if we can improve tolerability so that patients will receive a higher percentage of the treatment as planned.

Metastatic Castration Resistant Prostate Cancer

Jeffrey Yachnin M.D., PhD.100 participantsStarted Apr 2012

Stockholm, Sweden

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel

A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer

Related Searches

Vitamin D in Treating Patients With Prostate Cancer

Positron Emission Tomography in Prostate Cancer

Prostate Biomarker Study

Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide

Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer

A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer

Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer

Active Control of Prostatic Cancer With Criteria of Latence

Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy

Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation

Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients

A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer

Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer

Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.